Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-27 Cr₹-312 Cr₹-31 Cr₹113 Cr₹67 Cr

What is the latest Cash Flow from Investing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Investing Activities ratio of ORCHID PHARMA is ₹-27 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-27 Cr
Mar2024₹-312 Cr
Mar2023₹-31 Cr
Mar2022₹113 Cr
Mar2021₹67 Cr

How is Cash Flow from Investing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-27 Cr
Negative
Mar2024 ₹-312 Cr
Negative
Mar2023 ₹-31 Cr
Negative
Mar2022 ₹113 Cr
68.05
Mar2021 ₹67 Cr -

Compare Cash Flow from Investing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,487.9 Cr -2.4% -9.4% -50.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹107,100.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -4.6% -7% 1.8% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-2.4%

-9.4%

-50.8%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses